🔗 Share this article

Former Prime Minister Rishi Sunak has reinforced his appeal for a focused examination protocol for prostate cancer.

In a recently conducted discussion, he stated being "certain of the critical importance" of introducing such a system that would be economical, feasible and "preserve countless lives".

These statements emerge as the UK National Screening Committee reviews its decision from half a decade past not to recommend standard examination.

Journalistic accounts suggest the body may continue with its current stance.

Athlete Contributes Voice to Campaign

Olympic cycling champion Sir Chris Hoy, who has advanced prostate cancer, wants middle-aged males to be screened.

He proposes decreasing the eligibility age for accessing a PSA blood screening.

Currently, it is not standard practice to healthy individuals who are younger than fifty.

The PSA test is disputed though. Readings can rise for causes apart from cancer, such as inflammation, resulting in false positives.

Opponents argue this can result in unwarranted procedures and complications.

Focused Screening Initiative

The recommended screening programme would focus on males between 45 and 69 with a genetic predisposition of prostate gland cancer and black men, who face increased susceptibility.

This population comprises around 1.3 million individuals men in the UK.

Charity estimates suggest the system would require £25m a year - or about £18 per individual - comparable to colorectal and mammary cancer screening.

The estimate envisions twenty percent of suitable candidates would be contacted each year, with a seventy-two percent participation level.

Diagnostic activity (imaging and biopsies) would need to increase by almost a quarter, with only a moderate increase in healthcare personnel, as per the analysis.

Clinical Community Reaction

Several clinical specialists are sceptical about the effectiveness of examination.

They argue there is still a possibility that individuals will be intervened for the disease when it is not absolutely required and will then have to live with adverse outcomes such as incontinence and impotence.

One prominent urology expert commented that "The challenge is we can often detect conditions that might not necessitate to be treated and we risk inflicting harm...and my worry at the moment is that negative to positive ratio needs adjustment."

Individual Perspectives

Personal stories are also influencing the conversation.

One case concerns a 66-year-old who, after requesting a prostate screening, was diagnosed with the condition at the age of 59 and was told it had metastasized to his pelvis.

He has since experienced chemical therapy, beam therapy and hormone treatment but is not curable.

The patient supports examination for those who are genetically predisposed.

"That is essential to me because of my children – they are in their late thirties and early forties – I want them screened as promptly. If I had been tested at fifty I am certain I might not be in the situation I am today," he said.

Future Steps

The National Screening Committee will have to weigh up the evidence and perspectives.

While the latest analysis says the implications for workforce and capacity of a testing initiative would be achievable, others have maintained that it would redirect scanning capacity otherwise allocated to individuals being cared for for alternative medical problems.

The current debate highlights the complicated trade-off between timely diagnosis and likely unnecessary management in prostate gland cancer management.